Business Description
Shandong Sito Bio-technology Co Ltd
ISIN : CNE100002F36
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.21 | |||||
Equity-to-Asset | 0.63 | |||||
Debt-to-Equity | 0.36 | |||||
Debt-to-EBITDA | 19.02 | |||||
Interest Coverage | 1.93 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.89 | |||||
Beneish M-Score | -1.91 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9.6 | |||||
3-Year Book Growth Rate | 3.5 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 10.37 | |||||
9-Day RSI | 20.68 | |||||
14-Day RSI | 31.04 | |||||
6-1 Month Momentum % | 101.35 | |||||
12-1 Month Momentum % | 19.34 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.38 | |||||
Quick Ratio | 0.67 | |||||
Cash Ratio | 0.15 | |||||
Days Inventory | 307.21 | |||||
Days Sales Outstanding | 82.73 | |||||
Days Payable | 121.02 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.2 | |||||
Dividend Payout Ratio | 5.29 | |||||
3-Year Dividend Growth Rate | -35.2 | |||||
Forward Dividend Yield % | 2.2 | |||||
5-Year Yield-on-Cost % | 2.11 | |||||
3-Year Average Share Buyback Ratio | -3.3 | |||||
Shareholder Yield % | 2.2 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 22.2 | |||||
Operating Margin % | 5.84 | |||||
Net Margin % | -0.08 | |||||
FCF Margin % | 8.09 | |||||
ROE % | -0.04 | |||||
ROA % | -0.03 | |||||
ROIC % | -6.03 | |||||
ROC (Joel Greenblatt) % | 1.67 | |||||
ROCE % | 1.66 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 21180 | |||||
PE Ratio without NRI | 249.18 | |||||
Shiller PE Ratio | 41.53 | |||||
PS Ratio | 3.47 | |||||
PB Ratio | 2.07 | |||||
Price-to-Tangible-Book | 2.29 | |||||
Price-to-Free-Cash-Flow | 46.36 | |||||
Price-to-Operating-Cash-Flow | 26.51 | |||||
EV-to-EBIT | 122.92 | |||||
EV-to-EBITDA | 122.92 | |||||
EV-to-Revenue | 3.99 | |||||
EV-to-FCF | 49.31 | |||||
Price-to-Projected-FCF | 9.76 | |||||
Price-to-Graham-Number | 5.04 | |||||
Price-to-Net-Current-Asset-Value | 20.17 | |||||
Earnings Yield (Greenblatt) % | 0.81 | |||||
FCF Yield % | 2.26 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Shandong Sito Bio-technology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 1,121.592 | ||
EPS (TTM) (Â¥) | 0.001 | ||
Beta | 1.11 | ||
Volatility % | 87.88 | ||
14-Day RSI | 31.04 | ||
14-Day ATR (Â¥) | 1.32974 | ||
20-Day SMA (Â¥) | 23.54 | ||
12-1 Month Momentum % | 19.34 | ||
52-Week Range (Â¥) | 10.66 - 31.63 | ||
Shares Outstanding (Mil) | 189.7 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Shandong Sito Bio-technology Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Shandong Sito Bio-technology Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Shandong Sito Bio-technology Co Ltd Frequently Asked Questions
What is Shandong Sito Bio-technology Co Ltd(SZSE:300583)'s stock price today?
When is next earnings date of Shandong Sito Bio-technology Co Ltd(SZSE:300583)?
Does Shandong Sito Bio-technology Co Ltd(SZSE:300583) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |